| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1756-185X.2011.01698.X |
| P698 | PubMed publication ID | 22212605 |
| P50 | author | Tamer Gheita | Q79196805 |
| P2093 | author name string | Amal Rizk | |
| Abeer Abdallah | |||
| Sahar Nassef | |||
| P2860 | cites work | Unaltered TNF-alpha production by macrophages and monocytes in diet-induced obesity in the rat. | Q24795937 |
| Update on obesity | Q28283122 | ||
| Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
| The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. | Q31114844 | ||
| Obesity and its measurement in a community‐based sample of women with systemic lupus erythematosus | Q34440634 | ||
| Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management | Q35179614 | ||
| Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus | Q35552185 | ||
| African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV) | Q35953274 | ||
| Leptin, from fat to inflammation: old questions and new insights. | Q36005249 | ||
| 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus | Q36290168 | ||
| Developments in the scientific understanding of lupus | Q36993221 | ||
| Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies | Q37167998 | ||
| The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus | Q40974327 | ||
| Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients | Q41943173 | ||
| Metabolic syndrome in systemic lupus erythematosus: lower prevalence in Brazil than in the USA | Q42753840 | ||
| Risk factors for accelerated atherosclerosis in patients with systemic lupus erythematosus. | Q43049585 | ||
| Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients | Q43162047 | ||
| Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
| Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus. | Q46036146 | ||
| Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. | Q51260397 | ||
| The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus. | Q51500769 | ||
| Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus. | Q51786420 | ||
| Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors. | Q53270426 | ||
| TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. | Q53923210 | ||
| Fitness, fatigue, disease activity, and quality of life in pediatric lupus | Q57538184 | ||
| Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype | Q58327985 | ||
| P433 | issue | 3 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| obesity | Q12174 | ||
| lupus erythematosus | Q188297 | ||
| atherosclerosis | Q12252367 | ||
| quality of life | Q13100823 | ||
| P304 | page(s) | 261-267 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | International Journal of Rheumatic Diseases | Q15764244 |
| P1476 | title | The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis | |
| P478 | volume | 15 |
| Q37690605 | Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q50907604 | Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus. |
| Q37521919 | Genome-wide profiling identifies associations between lupus nephritis and differential methylation of genes regulating tissue hypoxia and type 1 interferon responses. |
| Q47216525 | Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus? |
| Q34611614 | Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease |
| Q92542367 | Improved prediction of HIT in the SICU using an improved model of the Warkentin 4-T system: 3-T |
| Q53698234 | Living with systemic lupus erythematosus in the developing world. |
| Q34488394 | Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). |
| Q64111768 | Study of MRI brain findings and carotid US features in systemic sclerosis patients, relationship with disease parameters |
| Q51122523 | Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices. |
| Q38960221 | The African Lupus Genetics Network (ALUGEN) registry: standardized, prospective follow-up studies in African patients with systemic lupus erythematosus |
| Q57790874 | The impact of obesity on SLE disease activity: findings from the Southern California Lupus Registry (SCOLR) |
Search more.